Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 9,349-9,360 of 23,847

Drug study icon

TerminatedNCT00412620

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anaheim

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Argentina, Mexico
Sponsor: Abbott
Condition: Schizophrenia

Drug study icon

CompletedNCT00106405

An Evaluation of the Safety and Efficacy of Memantine in people with Acute Mania Associated With Bipolarity type I

This study is completed in the United States. It focuses on manic episodes in bipolarity type I.

Multiple locations, including National City

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Forest Laboratories
Condition: Bipolarity

Drug study icon

CompletedNCT06215261

An Evaluation of the Safety and Efficacy of Methylone for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Lauderhill

PTSDDrugFrom 18 Years to 70 Years

Countries: United States, Australia, United Kingdom
Sponsor: Transcend Therapeutics
Condition: PTSD

Device study icon

CompletedNCT02229903

An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles

OCDDeviceFrom 22 Years to 68 Years

Countries: United States, Canada, Israel
Sponsor: Brainsway
Condition: OCD

Behavioral study icon

CompletedNCT00387855

An Evaluation of the SOS (Suicide prevention) Program

This summary needs review. Please check the official study record and contact the research team for details.

In Farmington

SuicidalityBehavioral

Countries: United States
Sponsor: UConn Health
Condition: Suicidality

Behavioral study icon

Enrolling By InvitationNCT06483412

An Evaluation of the Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention

This summary needs review. Please check the official study record and contact the research team for details.

In Palo Alto

AddictionBehavioralFrom 14 Years to 18 Years

Countries: United States
Sponsor: Stanford University
Condition: Addiction

Other study type icon

CompletedNCT01502436

An Exploration of the Relationship Between Chronic Pain and Suicide prevention Among Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In Denver

Suicidality, PTSDOtherFrom 18 Years to 89 Years

Countries: United States
Sponsor: VA Eastern Colorado Health Care System
Condition: Suicidality, PTSD

Behavioral study icon

CompletedNCT05737550

New Mobile Phone Application Measuring Eye Parameters of Eyes for Addiction

This study is completed in Sweden. It is testing new Mobile Phone Application Measuring Eye Parameters of Eyes for Addiction.

In Uppsala

AddictionBehavioralOver 18 Years

Countries: Sweden
Sponsor: Kontigo Care AB
Condition: Addiction

Drug study icon

TerminatedNCT05741502

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Columbus

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Ohio State University
Condition: Schizophrenia

Drug study icon

CompletedNCT00996242

An Exploratory Open Label Study of Adjunctive L-lysine Treatment in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Gothenburg

SchizophreniaDrugFrom 23 Years to 56 Years

Countries: Sweden
Sponsor: Göteborg University
Condition: Schizophrenia

Drug study icon

CompletedNCT00257023

An Exploratory Study on the Safety and Effectiveness of Paliperidone in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

SchizophreniaDrugFrom 20 Years to 64 Years

Countries
Sponsor: Janssen Pharmaceutical K.K.
Condition: Schizophrenia

Drug study icon

CompletedNCT00683462

An Exploratory study of AZD3480 (TC-1734) for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In Burlington

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.